Search research articles
Contact Us
Filters
Showing results (401-410 of 422) with videos related to
Page
of 43
Sort By:
The Journal of Antimicrobial Chemotherapy
|
November 1, 1982
Comparative study of ceftizoxime and cefamandole in the treatment of bronchopulmonary infections
J L LeFrock, A Molavi, A L Lentnek, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems
|
April 18, 2002
SB-242235, a selective inhibitor of p38 mitogen-activated protein kinase. I: preclinical pharmacokinetics
K W Ward, J W Proksch, K L Salyers, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 1, 1990
Cyclophosphamide, carmustine, and etoposide with autologous bone marrow transplantation in refractory Hodgkin's disease and non-Hodgkin's lymphoma: a dose-finding study
C Wheeler, J H Antin, W H Churchill, et al.
Journal of General Internal Medicine
|
March 9, 2017
A Health Services Research Agenda for Bariatric Surgery Within the Veterans Health Administration
L M Funk, W Gunnar, J A Dominitz, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
September 23, 1997
High prevalence of GAD65 (and IA-2) antibodies in Japanese IDDM patients by a new immunoprecipitation assay based on recombinant human GAD65
H Akamine, I Komiya, T Shimabukuro, et al.
The Journal of Clinical Investigation
|
June 7, 2000
Antagonizing the parathyroid calcium receptor stimulates parathyroid hormone secretion and bone formation in osteopenic rats
M Gowen, G B Stroup, R A Dodds, et al.
Bioorganic & Medicinal Chemistry Letters
|
July 16, 1999
Orally bioavailable nonpeptide vitronectin receptor antagonists containing 2-aminopyridine arginine mimetics
R M Keenan, W H Miller, L S Barton, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems
|
January 5, 2002
Preclinical pharmacokinetics of SB-203580, a potent inhibitor of p38 mitogen-activated protein kinase
K W Ward, J W Prokscht, L M Azzaranot, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
October 5, 2001
Potent and selective inhibition of human cathepsin K leads to inhibition of bone resorption in vivo in a nonhuman primate
G B Stroup, M W Lark, D F Veber, et al.
Lancet (London, England)
|
May 24, 1975
Letter: Nomenclature of thyroid-stimulating antibodies
D D Adams, S Dirmikis, D Doniach, et al.
Page
of 43
Search research articles
Search
Showing results (401-410 of 422) with videos related to
Sort By:
Page
of 43
The Journal of Antimicrobial Chemotherapy
|
November 1, 1982
Comparative study of ceftizoxime and cefamandole in the treatment of bronchopulmonary infections
J L LeFrock, A Molavi, A L Lentnek, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems
|
April 18, 2002
SB-242235, a selective inhibitor of p38 mitogen-activated protein kinase. I: preclinical pharmacokinetics
K W Ward, J W Proksch, K L Salyers, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 1, 1990
Cyclophosphamide, carmustine, and etoposide with autologous bone marrow transplantation in refractory Hodgkin's disease and non-Hodgkin's lymphoma: a dose-finding study
C Wheeler, J H Antin, W H Churchill, et al.
Journal of General Internal Medicine
|
March 9, 2017
A Health Services Research Agenda for Bariatric Surgery Within the Veterans Health Administration
L M Funk, W Gunnar, J A Dominitz, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
September 23, 1997
High prevalence of GAD65 (and IA-2) antibodies in Japanese IDDM patients by a new immunoprecipitation assay based on recombinant human GAD65
H Akamine, I Komiya, T Shimabukuro, et al.
The Journal of Clinical Investigation
|
June 7, 2000
Antagonizing the parathyroid calcium receptor stimulates parathyroid hormone secretion and bone formation in osteopenic rats
M Gowen, G B Stroup, R A Dodds, et al.
Bioorganic & Medicinal Chemistry Letters
|
July 16, 1999
Orally bioavailable nonpeptide vitronectin receptor antagonists containing 2-aminopyridine arginine mimetics
R M Keenan, W H Miller, L S Barton, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems
|
January 5, 2002
Preclinical pharmacokinetics of SB-203580, a potent inhibitor of p38 mitogen-activated protein kinase
K W Ward, J W Prokscht, L M Azzaranot, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
October 5, 2001
Potent and selective inhibition of human cathepsin K leads to inhibition of bone resorption in vivo in a nonhuman primate
G B Stroup, M W Lark, D F Veber, et al.
Lancet (London, England)
|
May 24, 1975
Letter: Nomenclature of thyroid-stimulating antibodies
D D Adams, S Dirmikis, D Doniach, et al.
Page
of 43